MIRABEGRON

MIRABEGRON was reported 39172 times

MIRABEGRON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 80 0.5369
1 HYPOCHOLESTEROLAEMIA 99 0.2805
2 FACET JOINT SYNDROME 663 0.2034
3 RESIDUAL URINE VOLUME INCREASED 20 0.1695
4 PERIPHERAL VENOUS DISEASE 657 0.1607
5 OVERLAP SYNDROME 103 0.1471
6 ONYCHOMADESIS 567 0.1350
7 BLEPHAROSPASM 824 0.1307
8 SWOLLEN JOINT COUNT 28 0.1120
9 RHEUMATIC FEVER 454 0.1017
10 BREAST CANCER STAGE III 657 0.1013
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 662 0.0923
12 ONYCHOMYCOSIS 405 0.0922
13 DUODENAL ULCER PERFORATION 652 0.0876
14 LUPUS VULGARIS 106 0.0841
15 INFUSION SITE REACTION 249 0.0833
16 MUSCLE INJURY 631 0.0761
17 FOLLICULITIS 773 0.0736
18 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 40 0.0713
19 DISLOCATION OF VERTEBRA 153 0.0670
20 NAIL DISORDER 569 0.0650
21 HYPERCHOLESTEROLAEMIA 624 0.0646
22 LIP DRY 582 0.0640
23 NOCTURIA 775 0.0638
24 HELICOBACTER INFECTION 651 0.0633
25 HYPERTONIC BLADDER 182 0.0630
26 BURSITIS 754 0.0621
27 PEMPHIGUS 768 0.0614
28 FINGER DEFORMITY 283 0.0584
29 C-REACTIVE PROTEIN ABNORMAL 373 0.0581
30 WOUND INFECTION 608 0.0555
31 DEEP VEIN THROMBOSIS POSTOPERATIVE 111 0.0554
32 VASCULAR STENOSIS 19 0.0552
33 X-RAY ABNORMAL 97 0.0542
34 URGE INCONTINENCE 47 0.0540
35 URINE FLOW DECREASED 121 0.0506
36 LIVE BIRTH 420 0.0502
37 BACK INJURY 542 0.0498
38 HAND DEFORMITY 643 0.0490
39 JOINT RANGE OF MOTION DECREASED 625 0.0466
40 SWOLLEN JOINT COUNT INCREASED 147 0.0461
41 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 93 0.0448
42 SYNOVITIS 801 0.0444
43 PERICARDITIS 739 0.0439
44 BLADDER SPASM 82 0.0438
45 RETINITIS 75 0.0434
46 SINONASAL OBSTRUCTION 17 0.0423
47 GRIP STRENGTH DECREASED 372 0.0422
48 TASTE DISORDER 803 0.0395
49 OBESITY 600 0.0376
50 PRODUCT LABEL CONFUSION 216 0.0370
51 PORPHYRIA ACUTE 53 0.0369
52 IRRITABLE BOWEL SYNDROME 759 0.0354
53 GLOSSODYNIA 788 0.0352
54 MICTURITION URGENCY 366 0.0320
55 FIBROMYALGIA 716 0.0294
56 CONGENITAL ANOMALY 226 0.0292
57 FORCED VITAL CAPACITY DECREASED 19 0.0291
58 BONE EROSION 103 0.0291
59 URINARY INCONTINENCE 857 0.0289
60 BLADDER DISCOMFORT 36 0.0289
61 C-REACTIVE PROTEIN 26 0.0280
62 BRONCHIAL WALL THICKENING 20 0.0278
63 COELIAC DISEASE 272 0.0277
64 BLADDER PAIN 87 0.0274
65 WOUND 741 0.0265
66 EPILEPSY 799 0.0261
67 URINARY RETENTION 812 0.0243
68 TYPE 2 DIABETES MELLITUS 798 0.0237
69 UPPER AIRWAY OBSTRUCTION 20 0.0225
70 LIVER INJURY 550 0.0224
71 C-REACTIVE PROTEIN INCREASED 812 0.0223
72 SPUTUM RETENTION 22 0.0222
73 IMPAIRED HEALING 722 0.0220
74 LIVER FUNCTION TEST INCREASED 471 0.0219
75 CYSTITIS INTERSTITIAL 35 0.0217
76 RHEUMATOID FACTOR POSITIVE 125 0.0216
77 BLADDER OPERATION 25 0.0214
78 SYSTEMIC LUPUS ERYTHEMATOSUS 760 0.0214
79 CONTRAINDICATED PRODUCT ADMINISTERED 642 0.0212
80 NIGHT SWEATS 682 0.0211
81 NEUROGENIC BLADDER 44 0.0208
82 POLLAKIURIA 859 0.0206
83 EXOSTOSIS 188 0.0206
84 ON AND OFF PHENOMENON 114 0.0205
85 BONE MARROW OEDEMA 21 0.0203
86 ADVERSE REACTION 266 0.0200
87 GAIT INABILITY 669 0.0200
88 URINE OUTPUT INCREASED 52 0.0199
89 PSORIATIC ARTHROPATHY 803 0.0198
90 STOMA SITE ERYTHEMA 36 0.0193
91 FREEZING PHENOMENON 70 0.0189
92 DEMENTIA WITH LEWY BODIES 21 0.0189
93 DRUG DISPENSED TO WRONG PATIENT 18 0.0189
94 BLADDER DISORDER 187 0.0188
95 OSTEOARTHRITIS 789 0.0186
96 BLADDER CATHETERISATION 18 0.0186
97 DRY MOUTH 1502 0.0185
98 URINARY HESITATION 43 0.0180
99 INTENTIONAL PRODUCT MISUSE 1549 0.0177
100 NORMAL NEWBORN 96 0.0176
101 BLADDER DYSFUNCTION 18 0.0175
102 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1147 0.0161
103 UPPER RESPIRATORY TRACT INFLAMMATION 19 0.0158
104 CYSTITIS NONINFECTIVE 21 0.0156
105 LOWER RESPIRATORY TRACT INFECTION 703 0.0154
106 BLOOD CHOLESTEROL INCREASED 720 0.0154
107 STOMA SITE DISCHARGE 42 0.0153
108 ESSENTIAL HYPERTENSION 28 0.0153
109 INCONTINENCE 160 0.0151
110 INABILITY TO AFFORD MEDICATION 149 0.0150
111 STOMA SITE HAEMORRHAGE 23 0.0149
112 DRUG TOLERANCE 74 0.0146
113 STOMA SITE INFECTION 19 0.0146
114 INFLAMMATION 753 0.0146
115 THERAPEUTIC PRODUCT EFFECT DECREASED 647 0.0144
116 LUNG DISORDER 706 0.0144
117 DRUG EFFECT INCOMPLETE 522 0.0144
118 JOINT INSTABILITY 20 0.0143
119 INFUSION RELATED REACTION 930 0.0140
120 INHIBITORY DRUG INTERACTION 22 0.0139
121 BLOOD PRESSURE DIASTOLIC ABNORMAL 35 0.0137
122 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152 0.0137
123 WALKING AID USER 90 0.0136
124 URINARY TRACT INFECTION BACTERIAL 34 0.0134
125 INTENTIONAL PRODUCT USE ISSUE 1170 0.0133
126 BLISTER 739 0.0131
127 ULCER HAEMORRHAGE 89 0.0131
128 BREAST CANCER STAGE II 109 0.0131
129 GASTROOESOPHAGEAL REFLUX DISEASE 1054 0.0131
130 STEROID DIABETES 19 0.0127
131 ARTHROPATHY 689 0.0124
132 URINE ODOUR ABNORMAL 72 0.0122
133 MUSCULOSKELETAL PAIN 632 0.0121
134 URINARY TRACT DISORDER 54 0.0120
135 MOBILITY DECREASED 859 0.0119
136 AUTOIMMUNE DISORDER 115 0.0118
137 WHEEZING 698 0.0118
138 NECK PAIN 653 0.0117
139 INFUSION SITE BRUISING 25 0.0116
140 SPINAL CORD INJURY 20 0.0115
141 STOMATITIS 690 0.0114
142 HYPERKINESIA 24 0.0113
143 GENITAL HERPES 17 0.0111
144 PUSTULAR PSORIASIS 38 0.0111
145 DYSURIA 404 0.0110
146 HEPATIC ENZYME INCREASED 745 0.0109
147 SLEEP DISORDER 764 0.0108
148 REHABILITATION THERAPY 41 0.0106
149 DRUG-INDUCED LIVER INJURY 331 0.0105
150 CYSTITIS 335 0.0105
151 HEPATITIS 269 0.0105
152 BREAST DISORDER 21 0.0103
153 INFUSION SITE DISCHARGE 18 0.0103
154 MATERNAL EXPOSURE DURING PREGNANCY 915 0.0103
155 BRADYKINESIA 60 0.0102
156 LUPUS-LIKE SYNDROME 91 0.0100
157 PRESCRIBED OVERDOSE 192 0.0099
158 TREATMENT NONCOMPLIANCE 541 0.0099
159 BLOOD PRESSURE INCREASED 1503 0.0098
160 SCIATICA 156 0.0098
161 MIGRAINE 934 0.0098
162 URINE ABNORMALITY 43 0.0094
163 PHARYNGEAL ERYTHEMA 20 0.0094
164 PRESCRIBED UNDERDOSE 188 0.0094
165 DRUG INTOLERANCE 903 0.0093
166 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 60 0.0092
167 ANAL INCONTINENCE 82 0.0091
168 CONFUSIONAL STATE 1470 0.0091
169 CLOSTRIDIUM TEST POSITIVE 20 0.0091
170 LIVING IN RESIDENTIAL INSTITUTION 17 0.0091
171 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 17 0.0090
172 MEMORY IMPAIRMENT 1238 0.0090
173 SPINAL STENOSIS 37 0.0090
174 BENIGN PROSTATIC HYPERPLASIA 46 0.0089
175 BLOOD PRESSURE SYSTOLIC ABNORMAL 22 0.0089
176 SPONDYLITIS 32 0.0088
177 SWELLING 819 0.0087
178 NONSPECIFIC REACTION 48 0.0087
179 LOWER LIMB FRACTURE 167 0.0087
180 BLOOD PRESSURE SYSTOLIC INCREASED 169 0.0087
181 SLOW SPEECH 21 0.0086
182 POSTURE ABNORMAL 28 0.0086
183 ILL-DEFINED DISORDER 521 0.0086
184 SLEEP DEFICIT 18 0.0085
185 EAR PAIN 164 0.0084
186 PERIPHERAL SWELLING 1283 0.0083
187 RASH VESICULAR 40 0.0083
188 HYPOAESTHESIA 1237 0.0083
189 EYE INJURY 25 0.0082
190 INFUSION SITE HAEMORRHAGE 27 0.0082
191 JOINT SWELLING 982 0.0081
192 URINARY TRACT INFECTION 1371 0.0080
193 VOLVULUS 19 0.0080
194 HALLUCINATION 602 0.0080
195 DRUG TOLERANCE DECREASED 22 0.0078
196 MUSCLE SPASTICITY 95 0.0077
197 CHRONIC SINUSITIS 29 0.0077
198 MUSCULAR WEAKNESS 877 0.0077
199 URINE ANALYSIS ABNORMAL 23 0.0077
200 HALLUCINATION, VISUAL 162 0.0077
201 GENERAL PHYSICAL HEALTH DETERIORATION 887 0.0077
202 BACTERIAL TEST POSITIVE 17 0.0076
203 DELUSION 118 0.0076
204 HYPERTENSION 1593 0.0075
205 RHEUMATOID ARTHRITIS 853 0.0075
206 PULMONARY FIBROSIS 144 0.0075
207 TREATMENT FAILURE 610 0.0074
208 INTERCEPTED MEDICATION ERROR 34 0.0073
209 DEMENTIA 202 0.0072
210 PARANASAL SINUS DISCOMFORT 27 0.0071
211 INTENTIONAL DRUG MISUSE 148 0.0071
212 HAEMORRHAGE URINARY TRACT 18 0.0071
213 MACULOPATHY 25 0.0070
214 PRODUCT COLOUR ISSUE 36 0.0070
215 WHEELCHAIR USER 31 0.0070
216 VULVOVAGINAL PRURITUS 35 0.0069
217 INJURY 485 0.0069
218 DELIRIUM 239 0.0069
219 ANXIETY DISORDER 23 0.0069
220 PARAESTHESIA 1081 0.0069
221 ORTHOSTATIC HYPOTENSION 119 0.0068
222 HEART RATE ABNORMAL 38 0.0068
223 BLOOD URINE PRESENT 128 0.0067
224 DYSPEPSIA 655 0.0067
225 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 114 0.0066
226 PHYSICAL DECONDITIONING 17 0.0066
227 SKIN ABRASION 31 0.0066
228 GASTROINTESTINAL MOTILITY DISORDER 35 0.0065
229 PERONEAL NERVE PALSY 37 0.0065
230 DRY THROAT 66 0.0065
231 OESOPHAGEAL DISORDER 25 0.0065
232 ENURESIS 26 0.0064
233 NASOPHARYNGITIS 1185 0.0064
234 EXPOSURE DURING PREGNANCY 397 0.0064
235 HEPATIC CIRRHOSIS 120 0.0064
236 PROSTATOMEGALY 25 0.0064
237 GOITRE 26 0.0063
238 MICTURITION DISORDER 22 0.0063
239 ABDOMINAL DISCOMFORT 1064 0.0063
240 CONSTIPATION 1361 0.0062
241 MUSCLE SPASMS 1141 0.0062
242 FALL 2069 0.0062
243 DIZZINESS POSTURAL 60 0.0062
244 SKIN LACERATION 67 0.0062
245 CHROMATURIA 139 0.0062
246 HYPOVENTILATION 20 0.0061
247 MATERNAL EXPOSURE TIMING UNSPECIFIED 23 0.0061
248 MUSCULOSKELETAL STIFFNESS 535 0.0061
249 DRUG PRESCRIBING ERROR 117 0.0061
250 INFUSION SITE SWELLING 38 0.0060
251 ASPIRATION 66 0.0060
252 ABDOMINAL PAIN UPPER 1240 0.0060
253 BLOOD PRESSURE FLUCTUATION 144 0.0060
254 URINE OUTPUT DECREASED 52 0.0059
255 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 100 0.0059
256 GASTROINTESTINAL DISORDER 525 0.0059
257 SKIN ODOUR ABNORMAL 23 0.0058
258 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 280 0.0058
259 FUNCTIONAL GASTROINTESTINAL DISORDER 20 0.0058
260 RHINORRHOEA 374 0.0058
261 DEVICE KINK 21 0.0058
262 BALANCE DISORDER 496 0.0057
263 INFUSION SITE ERYTHEMA 48 0.0057
264 TESTICULAR PAIN 18 0.0057
265 SLEEP APNOEA SYNDROME 108 0.0057
266 TONGUE DISCOMFORT 24 0.0056
267 DISCOMFORT 342 0.0056
268 FREQUENT BOWEL MOVEMENTS 151 0.0056
269 KIDNEY INFECTION 109 0.0055
270 IMMOBILE 24 0.0055
271 WHITE BLOOD CELL COUNT ABNORMAL 35 0.0055
272 INJECTION SITE REACTION 376 0.0055
273 MUSCLE RIGIDITY 65 0.0054
274 URTICARIA 909 0.0054
275 JOINT STIFFNESS 142 0.0054
276 THERAPEUTIC PRODUCT EFFECT VARIABLE 21 0.0054
277 DYSSTASIA 158 0.0054
278 FAECES HARD 21 0.0054
279 BLOOD PRESSURE ABNORMAL 107 0.0054
280 BLOOD PRESSURE DIASTOLIC DECREASED 39 0.0053
281 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 375 0.0053
282 MULTIPLE SCLEROSIS 252 0.0053
283 MYOSITIS 47 0.0052
284 DEPRESSION 1188 0.0052
285 DYSKINESIA 212 0.0052
286 MOUTH SWELLING 30 0.0052
287 VULVOVAGINAL PAIN 25 0.0052
288 HEAD INJURY 163 0.0051
289 GAIT DISTURBANCE 984 0.0051
290 VITAMIN D DEFICIENCY 50 0.0051
291 BACK DISORDER 83 0.0051
292 UROSEPSIS 47 0.0051
293 HOSPICE CARE 50 0.0051
294 HYPERTENSIVE CRISIS 56 0.0050
295 DRY EYE 250 0.0050
296 INCREASED TENDENCY TO BRUISE 46 0.0050
297 COMMUNICATION DISORDER 19 0.0050
298 ABDOMINAL DISTENSION 518 0.0050
299 FOOT DEFORMITY 55 0.0050
300 CERVICAL VERTEBRAL FRACTURE 17 0.0049
301 AORTIC STENOSIS 17 0.0049
302 KNEE ARTHROPLASTY 102 0.0048
303 ALOPECIA 949 0.0048
304 BOWEL MOVEMENT IRREGULARITY 37 0.0048
305 PRODUCT RESIDUE PRESENT 26 0.0048
306 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
307 CONCUSSION 37 0.0048
308 INITIAL INSOMNIA 49 0.0048
309 HIP ARTHROPLASTY 73 0.0048
310 BRONCHIECTASIS 32 0.0047
311 NEPHROGENIC ANAEMIA 22 0.0047
312 PRODUCT QUALITY ISSUE 644 0.0047
313 SPINAL OPERATION 58 0.0047
314 INCORRECT PRODUCT ADMINISTRATION DURATION 102 0.0047
315 OSTEOPOROSIS 193 0.0047
316 THYROID MASS 18 0.0047
317 HYPERLIPIDAEMIA 56 0.0047
318 LIP SWELLING 156 0.0047
319 SPINAL FUSION SURGERY 19 0.0047
320 CONTUSION 449 0.0047
321 CONDITION AGGRAVATED 1408 0.0046
322 PRODUCT USE IN UNAPPROVED INDICATION 1142 0.0046
323 DIZZINESS 2293 0.0046
324 SENSORY LOSS 37 0.0046
325 POLYP 30 0.0046
326 MYASTHENIA GRAVIS 37 0.0046
327 INFUSION SITE PAIN 59 0.0046
328 FAECALOMA 25 0.0046
329 GENERAL SYMPTOM 34 0.0045
330 PROSTATIC DISORDER 25 0.0045
331 DRUG INEFFECTIVE 5971 0.0045
332 PRODUCT SIZE ISSUE 24 0.0045
333 INSOMNIA 1183 0.0044
334 WEIGHT FLUCTUATION 46 0.0044
335 SEASONAL ALLERGY 62 0.0044
336 ASTHENIA 1638 0.0044
337 HUMERUS FRACTURE 21 0.0044
338 HAEMOGLOBIN ABNORMAL 28 0.0043
339 JOINT DISLOCATION 46 0.0043
340 PRODUCT ADMINISTRATION INTERRUPTED 34 0.0043
341 NASAL DRYNESS 27 0.0043
342 LYMPHOCYTE COUNT DECREASED 76 0.0043
343 DECUBITUS ULCER 35 0.0043
344 HYPOKINESIA 62 0.0043
345 ORAL CANDIDIASIS 56 0.0042
346 RESPIRATORY DISORDER 127 0.0042
347 PRODUCT PRESCRIBING ERROR 101 0.0042
348 PELVIC FRACTURE 33 0.0042
349 SPINAL COMPRESSION FRACTURE 35 0.0042
350 MIDDLE INSOMNIA 79 0.0042
351 PRODUCT AVAILABILITY ISSUE 96 0.0042
352 POST PROCEDURAL INFECTION 34 0.0042
353 COGNITIVE DISORDER 195 0.0042
354 HIP FRACTURE 134 0.0042
355 PRE-EXISTING CONDITION IMPROVED 26 0.0042
356 LUMBAR VERTEBRAL FRACTURE 19 0.0041
357 UPPER-AIRWAY COUGH SYNDROME 34 0.0041
358 PRODUCT DOSE OMISSION IN ERROR 116 0.0041
359 UNDERDOSE 299 0.0041
360 WEIGHT INCREASED 917 0.0041
361 AMNESIA 266 0.0041
362 LIGAMENT RUPTURE 18 0.0041
363 TEMPERATURE INTOLERANCE 42 0.0041
364 MUSCLE STRAIN 35 0.0040
365 HALLUCINATIONS, MIXED 17 0.0040
366 OEDEMA 219 0.0040
367 RIB FRACTURE 83 0.0040
368 INFUSION SITE EXTRAVASATION 25 0.0040
369 HYPERSOMNIA 115 0.0040
370 IRON DEFICIENCY ANAEMIA 37 0.0040
371 FAECES SOFT 29 0.0040
372 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 218 0.0040
373 METASTATIC NEOPLASM 17 0.0039
374 DROOLING 27 0.0039
375 DEVICE OCCLUSION 55 0.0039
376 POLYURIA 32 0.0039
377 SYNOVIAL CYST 18 0.0039
378 DISABILITY 77 0.0039
379 SINUS DISORDER 77 0.0039
380 PRODUCT USE ISSUE 723 0.0038
381 MULTIPLE ALLERGIES 30 0.0038
382 BLOOD SODIUM DECREASED 72 0.0038
383 SALIVARY HYPERSECRETION 38 0.0038
384 HYPERVENTILATION 22 0.0038
385 DYSGRAPHIA 25 0.0038
386 CEREBRAL DISORDER 28 0.0038
387 NEURALGIA 92 0.0038
388 ABNORMAL DREAMS 104 0.0038
389 COMPRESSION FRACTURE 20 0.0037
390 INSURANCE ISSUE 57 0.0037
391 SCOLIOSIS 23 0.0037
392 CATARACT OPERATION 22 0.0037
393 ARTHRALGIA 1538 0.0037
394 THERAPY NON-RESPONDER 166 0.0037
395 ORAL DISORDER 27 0.0037
396 PRODUCT USE COMPLAINT 58 0.0037
397 ROAD TRAFFIC ACCIDENT 154 0.0037
398 HEADACHE 2301 0.0037
399 PAIN IN EXTREMITY 1075 0.0036
400 LIMB INJURY 99 0.0036
401 NIGHTMARE 126 0.0036
402 FEELING HOT 223 0.0036
403 PROSTATIC SPECIFIC ANTIGEN INCREASED 50 0.0036
404 LYMPHOEDEMA 25 0.0036
405 RESPIRATORY TRACT INFECTION 94 0.0036
406 FOREIGN BODY SENSATION IN EYES 23 0.0036
407 PNEUMONIA 1167 0.0036
408 MACULAR DEGENERATION 43 0.0036
409 SARCOIDOSIS 17 0.0036
410 SINUSITIS 363 0.0035
411 PRODUCT DISPENSING ERROR 77 0.0035
412 POOR QUALITY SLEEP 76 0.0035
413 DYSPHAGIA 335 0.0035
414 APHASIA 106 0.0035
415 HEAD DISCOMFORT 62 0.0035
416 PHARYNGEAL SWELLING 34 0.0035
417 HYDRONEPHROSIS 26 0.0035
418 NERVE COMPRESSION 32 0.0035
419 FRUSTRATION TOLERANCE DECREASED 28 0.0035
420 MULTIPLE SCLEROSIS RELAPSE 237 0.0035
421 ACCIDENTAL OVERDOSE 126 0.0034
422 MUSCULOSKELETAL DISCOMFORT 59 0.0034
423 RASH 1493 0.0034
424 ANKLE FRACTURE 53 0.0034
425 GROIN PAIN 30 0.0034
426 ATELECTASIS 33 0.0034
427 PRODUCTIVE COUGH 162 0.0034
428 CELLULITIS 171 0.0034
429 PRODUCT LABEL ISSUE 23 0.0034
430 PHARYNGITIS 42 0.0034
431 EAR INFECTION 90 0.0034
432 DECREASED APPETITE 785 0.0034
433 OSTEOPENIA 51 0.0034
434 THIRST 60 0.0034
435 PERIPHERAL COLDNESS 46 0.0033
436 BLOOD PRESSURE DECREASED 222 0.0033
437 INTERVERTEBRAL DISC PROTRUSION 73 0.0033
438 LIGAMENT SPRAIN 33 0.0033
439 HIP SURGERY 18 0.0033
440 HOT FLUSH 250 0.0033
441 CANDIDA INFECTION 56 0.0033
442 HYPERSENSITIVITY 615 0.0033
443 EXPIRED PRODUCT ADMINISTERED 110 0.0033
444 EXERCISE TOLERANCE DECREASED 19 0.0033
445 ESCHERICHIA INFECTION 27 0.0033
446 ACCIDENT 39 0.0033
447 RECTAL HAEMORRHAGE 140 0.0033
448 OFF LABEL USE 2852 0.0033
449 SINUS CONGESTION 44 0.0033
450 GLAUCOMA 62 0.0032
451 SWOLLEN TONGUE 100 0.0032
452 FLANK PAIN 30 0.0032
453 BACK PAIN 743 0.0032
454 ROTATOR CUFF SYNDROME 41 0.0032
455 EYE PAIN 180 0.0032
456 RESTLESS LEGS SYNDROME 58 0.0032
457 DIARRHOEA 2057 0.0032
458 SARS-COV-2 TEST POSITIVE 42 0.0032
459 ABNORMAL FAECES 26 0.0032
460 LIMB DISCOMFORT 98 0.0032
461 DIPLOPIA 82 0.0032
462 MUSCULOSKELETAL DISORDER 60 0.0031
463 DECREASED ACTIVITY 34 0.0031
464 NERVE INJURY 35 0.0031
465 ADVERSE EVENT 290 0.0031
466 PAIN 1921 0.0031
467 ORAL PAIN 70 0.0031
468 GASTROINTESTINAL INFECTION 28 0.0031
469 OEDEMA PERIPHERAL 380 0.0031
470 HYSTERECTOMY 27 0.0031
471 MOVEMENT DISORDER 100 0.0031
472 NASAL CONGESTION 183 0.0031
473 HAND FRACTURE 22 0.0031
474 ARTHROPOD BITE 23 0.0031
475 DERMATITIS ALLERGIC 39 0.0031
476 CARDIAC FLUTTER 20 0.0031
477 APHONIA 43 0.0031
478 DYSPHONIA 180 0.0031
479 ERECTILE DYSFUNCTION 79 0.0031
480 SPINAL OSTEOARTHRITIS 27 0.0031
481 OROPHARYNGEAL PAIN 283 0.0031
482 VISION BLURRED 419 0.0030
483 FATIGUE 2372 0.0030
484 PULMONARY THROMBOSIS 33 0.0030
485 CLOSTRIDIUM DIFFICILE INFECTION 66 0.0030
486 SKIN CANCER 65 0.0030
487 SPEECH DISORDER 158 0.0030
488 UPPER LIMB FRACTURE 60 0.0030
489 CHRONIC KIDNEY DISEASE 228 0.0030
490 BRONCHITIS 222 0.0030
491 FAECES DISCOLOURED 65 0.0030
492 TOOTH FRACTURE 33 0.0030
493 POST-TRAUMATIC STRESS DISORDER 20 0.0030
494 PSYCHIATRIC SYMPTOM 22 0.0030
495 VISUAL IMPAIRMENT 369 0.0030
496 HEART RATE INCREASED 294 0.0030
497 SPINAL DISORDER 28 0.0030
498 TENSION 18 0.0030
499 COVID-19 518 0.0029
500 VULVOVAGINAL BURNING SENSATION 18 0.0029
501 SUBARACHNOID HAEMORRHAGE 30 0.0029
502 MOTOR DYSFUNCTION 30 0.0029
503 SKIN INFECTION 33 0.0029
504 OCULAR DISCOMFORT 33 0.0029
505 SENSORY DISTURBANCE 47 0.0029
506 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
507 TENDON DISORDER 19 0.0029
508 FACIAL PAIN 26 0.0029
509 FEEDING DISORDER 59 0.0029
510 FOOT FRACTURE 55 0.0029
511 RENAL CYST 23 0.0029
512 SOMNAMBULISM 19 0.0029
513 ATRIAL FIBRILLATION 281 0.0029
514 NEPHROLITHIASIS 132 0.0029
515 HAEMORRHOIDS 56 0.0029
516 ORAL HERPES 56 0.0029
517 ATAXIA 34 0.0029
518 THERAPY CESSATION 147 0.0029
519 DISORIENTATION 113 0.0028
520 ODYNOPHAGIA 17 0.0028
521 KNEE OPERATION 28 0.0028
522 PRODUCT PACKAGING ISSUE 27 0.0028
523 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
524 SOMNOLENCE 568 0.0028
525 HYPOTHYROIDISM 90 0.0028
526 JOINT INJURY 60 0.0028
527 TREMOR 466 0.0028
528 BRAIN FOG 44 0.0028
529 INTENTIONAL DOSE OMISSION 80 0.0028
530 HAEMATURIA 96 0.0028
531 PRODUCT DISTRIBUTION ISSUE 26 0.0028
532 HICCUPS 23 0.0028
533 VOMITING 1317 0.0028
534 INGUINAL HERNIA 17 0.0028
535 OBSTRUCTIVE AIRWAYS DISORDER 31 0.0028
536 PARANOIA 48 0.0028
537 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
538 ONYCHOCLASIS 19 0.0028
539 NODULE 36 0.0028
540 OPTIC NEURITIS 25 0.0027
541 IMMUNODEFICIENCY 41 0.0027
542 ORAL DISCOMFORT 38 0.0027
543 MUSCLE TWITCHING 63 0.0027
544 SPINAL PAIN 32 0.0027
545 EYE INFLAMMATION 26 0.0027
546 MALAISE 1195 0.0027
547 ARRHYTHMIA 129 0.0027
548 IMPAIRED QUALITY OF LIFE 39 0.0027
549 RASH PRURITIC 147 0.0027
550 BODY HEIGHT DECREASED 29 0.0027
551 POOR VENOUS ACCESS 28 0.0027
552 BLOOD COUNT ABNORMAL 41 0.0027
553 CARDIAC FAILURE ACUTE 18 0.0027
554 DRUG INTERACTION 427 0.0027
555 PNEUMONIA ASPIRATION 67 0.0027
556 ASTHMA 303 0.0027
557 OXYGEN SATURATION DECREASED 150 0.0027
558 BEDRIDDEN 35 0.0027
559 HEART RATE IRREGULAR 60 0.0027
560 INFECTION 384 0.0027
561 MASS 37 0.0026
562 LOCALISED INFECTION 64 0.0026
563 RENAL PAIN 28 0.0026
564 IMPAIRED GASTRIC EMPTYING 36 0.0026
565 WHITE BLOOD CELL COUNT INCREASED 101 0.0026
566 ARTHRITIS 207 0.0026
567 EYE MOVEMENT DISORDER 18 0.0026
568 HYPOACUSIS 113 0.0026
569 BURNING SENSATION 184 0.0026
570 PULMONARY MASS 39 0.0026
571 LACRIMATION INCREASED 79 0.0026
572 THERAPEUTIC RESPONSE UNEXPECTED 117 0.0026
573 RHINITIS 21 0.0026
574 INTENTIONAL UNDERDOSE 19 0.0026
575 BODY TEMPERATURE INCREASED 53 0.0026
576 ANGINA PECTORIS 74 0.0026
577 INTRAOCULAR PRESSURE INCREASED 33 0.0026
578 VERTIGO 157 0.0026
579 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 87 0.0026
580 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 464 0.0026
581 FEELING JITTERY 49 0.0026
582 CORONAVIRUS INFECTION 17 0.0026
583 FLATULENCE 145 0.0026
584 FLUID RETENTION 130 0.0026
585 FEELING ABNORMAL 612 0.0026
586 DYSARTHRIA 96 0.0025
587 FUNGAL INFECTION 85 0.0025
588 SLUGGISHNESS 26 0.0025
589 ABDOMINAL PAIN 592 0.0025
590 ILLNESS 262 0.0025
591 BREAST PAIN 27 0.0025
592 DYSPNOEA 1423 0.0025
593 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 508 0.0025
594 PALPITATIONS 293 0.0025
595 UPPER RESPIRATORY TRACT INFECTION 115 0.0025
596 CHEST PAIN 458 0.0025
597 ADVERSE DRUG REACTION 222 0.0025
598 HIATUS HERNIA 32 0.0025
599 SCHIZOPHRENIA 30 0.0025
600 PRESYNCOPE 60 0.0025
601 HYPOPHAGIA 63 0.0025
602 FACIAL PARALYSIS 21 0.0025
603 PARKINSONISM 24 0.0025
604 VITAMIN D DECREASED 21 0.0025
605 COVID-19 PNEUMONIA 29 0.0025
606 SUBDURAL HAEMATOMA 35 0.0024
607 DENTAL CARIES 27 0.0024
608 COUGH 679 0.0024
609 PRODUCT DOSE OMISSION 158 0.0024
610 ACUTE CORONARY SYNDROME 20 0.0024
611 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 126 0.0024
612 THROAT TIGHTNESS 65 0.0024
613 LETHARGY 138 0.0024
614 NASAL DISCOMFORT 19 0.0024
615 INFLUENZA 266 0.0024
616 WEIGHT DECREASED 664 0.0024
617 FRACTURE 45 0.0024
618 LOSS OF CONSCIOUSNESS 304 0.0024
619 LABORATORY TEST ABNORMAL 70 0.0024
620 SKIN LESION 65 0.0024
621 FULL BLOOD COUNT ABNORMAL 25 0.0024
622 BLOOD IRON DECREASED 28 0.0024
623 PARAESTHESIA ORAL 34 0.0024
624 SMALL INTESTINAL OBSTRUCTION 29 0.0024
625 DISTURBANCE IN ATTENTION 127 0.0024
626 DEVICE DISLOCATION 102 0.0023
627 MUSCLE TIGHTNESS 38 0.0023
628 VITREOUS FLOATERS 23 0.0023
629 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
630 CYST 29 0.0023
631 LIVER DISORDER 103 0.0023
632 APHTHOUS ULCER 18 0.0023
633 PRODUCT DOSE OMISSION ISSUE 682 0.0023
634 CATARACT 138 0.0023
635 NAUSEA 1831 0.0023
636 EYE DISCHARGE 24 0.0023
637 POST PROCEDURAL COMPLICATION 44 0.0023
638 FEELING DRUNK 17 0.0023
639 INTESTINAL OBSTRUCTION 86 0.0023
640 HEART RATE DECREASED 80 0.0023
641 SNEEZING 51 0.0023
642 DEPRESSED MOOD 120 0.0023
643 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
644 ATRIAL FLUTTER 18 0.0023
645 EATING DISORDER 48 0.0023
646 MEDICATION ERROR 125 0.0022
647 ABNORMAL BEHAVIOUR 89 0.0022
648 SECRETION DISCHARGE 28 0.0022
649 BODY TEMPERATURE DECREASED 22 0.0022
650 AORTIC ANEURYSM 17 0.0022
651 LACERATION 21 0.0022
652 SWELLING FACE 145 0.0022
653 ELECTROCARDIOGRAM QT PROLONGED 80 0.0022
654 HYPOTENSION 446 0.0022
655 OROPHARYNGEAL DISCOMFORT 20 0.0022
656 RETCHING 47 0.0022
657 FOETAL EXPOSURE DURING PREGNANCY 179 0.0022
658 BLOOD MAGNESIUM DECREASED 19 0.0022
659 THINKING ABNORMAL 41 0.0022
660 PYELONEPHRITIS 19 0.0022
661 DERMATITIS CONTACT 25 0.0022
662 HEMIPARESIS 37 0.0022
663 PANCREATITIS 115 0.0022
664 TRANSIENT ISCHAEMIC ATTACK 73 0.0022
665 PERSONALITY CHANGE 20 0.0022
666 COORDINATION ABNORMAL 30 0.0021
667 SURGERY 126 0.0021
668 MENTAL IMPAIRMENT 52 0.0021
669 DEHYDRATION 286 0.0021
670 ADRENAL INSUFFICIENCY 26 0.0021
671 HALLUCINATION, AUDITORY 34 0.0021
672 PRURITUS GENERALISED 46 0.0021
673 ANXIETY 605 0.0021
674 RASH GENERALISED 55 0.0021
675 BASAL CELL CARCINOMA 33 0.0021
676 SPUTUM DISCOLOURED 20 0.0021
677 HERPES ZOSTER 121 0.0021
678 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
679 CARPAL TUNNEL SYNDROME 29 0.0021
680 PNEUMONIA BACTERIAL 19 0.0021
681 EYE SWELLING 77 0.0021
682 TINNITUS 95 0.0021
683 PRURITUS 793 0.0021
684 TOOTH ABSCESS 21 0.0021
685 BLOOD POTASSIUM DECREASED 62 0.0021
686 CHOKING 40 0.0020
687 GASTROENTERITIS VIRAL 37 0.0020
688 CEREBRAL INFARCTION 50 0.0020
689 SPINAL FRACTURE 41 0.0020
690 EAR DISCOMFORT 21 0.0020
691 COLD SWEAT 36 0.0020
692 CEREBRAL HAEMORRHAGE 73 0.0020
693 RENAL IMPAIRMENT 171 0.0020
694 PRODUCT ADMINISTRATION ERROR 41 0.0020
695 TACHYCARDIA 180 0.0020
696 TENDON RUPTURE 25 0.0020
697 RESTLESSNESS 74 0.0020
698 NEUROPATHY PERIPHERAL 192 0.0020
699 EYE IRRITATION 116 0.0020
700 FEELING COLD 56 0.0020
701 HUNGER 28 0.0020
702 THROAT IRRITATION 90 0.0020
703 GASTROINTESTINAL PAIN 22 0.0020
704 SYNCOPE 200 0.0020
705 HOSPITALISATION 307 0.0020
706 RENAL DISORDER 93 0.0020
707 PLATELET COUNT INCREASED 26 0.0020
708 TACHYPNOEA 27 0.0020
709 PELVIC PAIN 36 0.0020
710 TOOTH DISORDER 44 0.0020
711 UNRESPONSIVE TO STIMULI 51 0.0020
712 ERUCTATION 38 0.0020
713 HYPOKALAEMIA 90 0.0019
714 HYPERHIDROSIS 251 0.0019
715 SKIN FISSURES 38 0.0019
716 HAIR TEXTURE ABNORMAL 26 0.0019
717 FEMUR FRACTURE 60 0.0019
718 NERVOUSNESS 100 0.0019
719 DIVERTICULITIS 53 0.0019
720 TRANSFUSION 20 0.0019
721 INFLUENZA LIKE ILLNESS 157 0.0019
722 GOUT 34 0.0019
723 RED BLOOD CELL COUNT DECREASED 54 0.0019
724 RESPIRATORY TRACT CONGESTION 30 0.0019
725 RASH MACULAR 66 0.0019
726 EYE DISORDER 62 0.0019
727 MUSCULOSKELETAL CHEST PAIN 29 0.0019
728 TENDONITIS 29 0.0019
729 MENTAL STATUS CHANGES 52 0.0019
730 MOOD ALTERED 51 0.0019
731 MALIGNANT MELANOMA 25 0.0019
732 END STAGE RENAL DISEASE 34 0.0019
733 ILEUS 23 0.0018
734 BRAIN NEOPLASM 17 0.0018
735 BLOOD POTASSIUM INCREASED 30 0.0018
736 IMPAIRED DRIVING ABILITY 21 0.0018
737 EPISTAXIS 138 0.0018
738 BLINDNESS UNILATERAL 26 0.0018
739 BIPOLAR DISORDER 20 0.0018
740 THERAPEUTIC RESPONSE SHORTENED 61 0.0018
741 PROCEDURAL PAIN 51 0.0018
742 LYMPHOPENIA 26 0.0018
743 DYSPNOEA EXERTIONAL 69 0.0018
744 ACUTE KIDNEY INJURY 280 0.0018
745 BLOOD GLUCOSE FLUCTUATION 20 0.0018
746 TOOTH INFECTION 24 0.0018
747 PHARYNGEAL OEDEMA 28 0.0018
748 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
749 ACUTE RESPIRATORY FAILURE 35 0.0018
750 HERNIA 35 0.0018
751 PHOTOPHOBIA 34 0.0018
752 VIRAL INFECTION 60 0.0018
753 VASCULITIS 21 0.0018
754 FLUSHING 183 0.0018
755 THERAPY INTERRUPTED 128 0.0018
756 COMPLICATION ASSOCIATED WITH DEVICE 26 0.0018
757 THROMBOSIS 144 0.0018
758 CARDIOMEGALY 22 0.0018
759 GASTRITIS 47 0.0018
760 HEPATIC STEATOSIS 33 0.0018
761 TOOTH EXTRACTION 22 0.0018
762 DRUG DISPENSING ERROR 27 0.0018
763 METASTASES TO LIVER 31 0.0018
764 DEVICE RELATED INFECTION 27 0.0018
765 SCAB 20 0.0018
766 DYSTONIA 34 0.0018
767 WRIST FRACTURE 21 0.0018
768 PARALYSIS 25 0.0017
769 ABDOMINAL PAIN LOWER 44 0.0017
770 CHEST DISCOMFORT 177 0.0017
771 HYPOAESTHESIA ORAL 26 0.0017
772 GASTRIC DISORDER 59 0.0017
773 OSTEOMYELITIS 31 0.0017
774 BLOOD TEST ABNORMAL 24 0.0017
775 TUBULOINTERSTITIAL NEPHRITIS 32 0.0017
776 SPLENOMEGALY 20 0.0017
777 OCULAR HYPERAEMIA 81 0.0017
778 PYREXIA 590 0.0017
779 ACUTE MYOCARDIAL INFARCTION 50 0.0017
780 OVERDOSE 365 0.0017
781 THYROID DISORDER 26 0.0017
782 DEVICE ISSUE 151 0.0017
783 COLON CANCER 25 0.0017
784 AGITATION 123 0.0017
785 CARDIAC FAILURE CONGESTIVE 134 0.0017
786 TOOTHACHE 30 0.0017
787 COLITIS ULCERATIVE 74 0.0017
788 PREGNANCY 33 0.0016
789 CEREBROVASCULAR ACCIDENT 276 0.0016
790 PETECHIAE 17 0.0016
791 MYALGIA 274 0.0016
792 LOCAL SWELLING 28 0.0016
793 PLEURAL EFFUSION 97 0.0016
794 PULMONARY CONGESTION 21 0.0016
795 SKIN DISCOLOURATION 73 0.0016
796 ANGIOEDEMA 70 0.0016
797 MUSCLE ATROPHY 20 0.0016
798 CHOLECYSTECTOMY 18 0.0016
799 SEPSIS 175 0.0016
800 SEIZURE 181 0.0016
801 PSYCHOTIC DISORDER 46 0.0016
802 DEAFNESS 40 0.0015
803 SKIN DISORDER 51 0.0015
804 WHITE BLOOD CELL COUNT DECREASED 165 0.0015
805 RESPIRATORY DISTRESS 42 0.0015
806 PNEUMOTHORAX 24 0.0015
807 SKIN ULCER 39 0.0015
808 APATHY 22 0.0015
809 EYE INFECTION 17 0.0015
810 CARDIAC DISORDER 140 0.0015
811 DIABETES MELLITUS 114 0.0015
812 AGEUSIA 37 0.0015
813 MOUTH ULCERATION 31 0.0015
814 MENTAL DISORDER 64 0.0015
815 PALLOR 40 0.0015
816 HAEMATOCRIT DECREASED 29 0.0015
817 AGGRESSION 73 0.0015
818 CHILLS 170 0.0014
819 SEXUAL DYSFUNCTION 17 0.0014
820 NERVOUS SYSTEM DISORDER 45 0.0014
821 IMMUNE SYSTEM DISORDER 19 0.0014
822 HYPONATRAEMIA 80 0.0014
823 SKIN REACTION 20 0.0014
824 INCREASED APPETITE 27 0.0014
825 DRUG DOSE OMISSION 233 0.0014
826 PULMONARY OEDEMA 63 0.0014
827 BONE PAIN 82 0.0014
828 UNEVALUABLE EVENT 105 0.0014
829 CARDIAC FAILURE 111 0.0014
830 ABSCESS 22 0.0014
831 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
832 DEVICE USE ISSUE 24 0.0014
833 COLITIS 52 0.0014
834 DEPRESSED LEVEL OF CONSCIOUSNESS 54 0.0014
835 HYPOXIA 48 0.0014
836 HAEMOPTYSIS 38 0.0014
837 HAEMATOMA 35 0.0013
838 SKIN HAEMORRHAGE 20 0.0013
839 EYE HAEMORRHAGE 18 0.0013
840 SCAR 23 0.0013
841 FULL BLOOD COUNT DECREASED 27 0.0013
842 PRODUCT PHYSICAL ISSUE 27 0.0013
843 BLINDNESS 54 0.0013
844 HYPERKALAEMIA 46 0.0013
845 EYE PRURITUS 44 0.0013
846 GLYCOSYLATED HAEMOGLOBIN INCREASED 33 0.0013
847 PAIN IN JAW 37 0.0013
848 RENAL FAILURE 172 0.0013
849 HAEMOGLOBIN DECREASED 133 0.0013
850 HYPOMAGNESAEMIA 18 0.0013
851 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
852 HYPERGLYCAEMIA 47 0.0013
853 CHOLELITHIASIS 42 0.0013
854 DYSGEUSIA 95 0.0013
855 MULTIPLE FRACTURES 21 0.0013
856 HAEMORRHAGE INTRACRANIAL 19 0.0013
857 CRYING 46 0.0013
858 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
859 PANIC ATTACK 46 0.0013
860 BLOOD GLUCOSE INCREASED 237 0.0013
861 DEATH 1078 0.0013
862 PNEUMONITIS 34 0.0012
863 DRUG EFFECT DECREASED 67 0.0012
864 GASTROENTERITIS 18 0.0012
865 DRY SKIN 163 0.0012
866 THERAPY PARTIAL RESPONDER 19 0.0012
867 ANAEMIA 232 0.0012
868 STAPHYLOCOCCAL INFECTION 40 0.0012
869 TARDIVE DYSKINESIA 34 0.0012
870 SEPTIC SHOCK 52 0.0012
871 ECONOMIC PROBLEM 18 0.0012
872 THERAPEUTIC RESPONSE DECREASED 72 0.0012
873 ENCEPHALOPATHY 29 0.0012
874 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
875 BLOOD CREATININE INCREASED 76 0.0012
876 HAEMATOCHEZIA 64 0.0012
877 LUNG INFECTION 18 0.0012
878 ANAPHYLACTIC REACTION 64 0.0012
879 ERYTHEMA 238 0.0012
880 ALANINE AMINOTRANSFERASE INCREASED 71 0.0012
881 RASH ERYTHEMATOUS 55 0.0011
882 PRODUCT PRESCRIBING ISSUE 25 0.0011
883 LUNG NEOPLASM MALIGNANT 47 0.0011
884 MELAENA 25 0.0011
885 EMOTIONAL DISORDER 35 0.0011
886 NEOPLASM MALIGNANT 75 0.0011
887 GALLBLADDER DISORDER 20 0.0011
888 HYPOCALCAEMIA 21 0.0011
889 SEDATION 29 0.0011
890 IRRITABILITY 66 0.0011
891 HYPOGLYCAEMIA 53 0.0011
892 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
893 NEUTROPHIL COUNT DECREASED 44 0.0011
894 RENAL INJURY 32 0.0011
895 DEEP VEIN THROMBOSIS 70 0.0011
896 INTERSTITIAL LUNG DISEASE 52 0.0011
897 PULMONARY EMBOLISM 101 0.0011
898 NO ADVERSE EVENT 192 0.0011
899 APPLICATION SITE PRURITUS 24 0.0011
900 GASTRIC ULCER 20 0.0011
901 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
902 PLATELET COUNT DECREASED 112 0.0010
903 DERMATITIS ATOPIC 55 0.0010
904 BONE DISORDER 19 0.0010
905 PERICARDIAL EFFUSION 24 0.0010
906 EXTRA DOSE ADMINISTERED 42 0.0010
907 ANGER 35 0.0010
908 SKIN EXFOLIATION 87 0.0010
909 BRADYCARDIA 54 0.0010
910 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
911 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
912 ABASIA 25 0.0010
913 PSORIASIS 132 0.0010
914 SUICIDAL IDEATION 92 0.0010
915 INJECTION SITE MASS 37 0.0010
916 CIRCULATORY COLLAPSE 17 0.0010
917 ANHEDONIA 26 0.0010
918 PRODUCT STORAGE ERROR 85 0.0010
919 BACTERIAL INFECTION 18 0.0010
920 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
921 PULMONARY HYPERTENSION 20 0.0010
922 RESPIRATORY FAILURE 70 0.0010
923 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
924 ECZEMA 50 0.0010
925 INCORRECT DOSE ADMINISTERED 213 0.0009
926 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
927 BLOOD GLUCOSE ABNORMAL 17 0.0009
928 HAEMORRHAGE 96 0.0009
929 MOOD SWINGS 29 0.0009
930 PRODUCT SUBSTITUTION ISSUE 52 0.0009
931 VISUAL ACUITY REDUCED 30 0.0009
932 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
933 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0009
934 DEVICE BREAKAGE 36 0.0009
935 DEVICE LEAKAGE 38 0.0009
936 LYMPHADENOPATHY 31 0.0009
937 PLASMA CELL MYELOMA 34 0.0009
938 INJECTION SITE URTICARIA 21 0.0009
939 FEAR 23 0.0009
940 INJECTION SITE PRURITUS 57 0.0009
941 RASH PAPULAR 19 0.0008
942 PANCYTOPENIA 47 0.0008
943 APPLICATION SITE ERYTHEMA 22 0.0008
944 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
945 CORONARY ARTERY DISEASE 25 0.0008
946 TOOTH LOSS 17 0.0008
947 PAIN OF SKIN 22 0.0008
948 MYOCARDIAL INFARCTION 141 0.0008
949 NEOPLASM PROGRESSION 28 0.0008
950 INJECTION SITE BRUISING 64 0.0008
951 FEBRILE NEUTROPENIA 53 0.0008
952 DISEASE RECURRENCE 38 0.0008
953 BONE DENSITY DECREASED 25 0.0008
954 LIVER FUNCTION TEST ABNORMAL 23 0.0008
955 DISEASE PROGRESSION 92 0.0008
956 APPLICATION SITE PAIN 17 0.0008
957 PROSTATE CANCER 62 0.0008
958 RHABDOMYOLYSIS 32 0.0008
959 NEEDLE ISSUE 22 0.0008
960 BLADDER CANCER 44 0.0007
961 SHOCK 17 0.0007
962 VAGINAL HAEMORRHAGE 32 0.0007
963 INTENTIONAL OVERDOSE 47 0.0007
964 SKIN IRRITATION 33 0.0007
965 THROMBOCYTOPENIA 79 0.0007
966 MALIGNANT NEOPLASM PROGRESSION 72 0.0007
967 WITHDRAWAL SYNDROME 28 0.0007
968 CARDIAC ARREST 53 0.0006
969 BLOOD GLUCOSE DECREASED 30 0.0006
970 LEUKOPENIA 31 0.0006
971 ASCITES 18 0.0006
972 BREAST CANCER 57 0.0006
973 HEPATIC FUNCTION ABNORMAL 22 0.0006
974 INJECTION SITE RASH 18 0.0006
975 DEVICE MALFUNCTION 41 0.0006
976 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27 0.0006
977 EMOTIONAL DISTRESS 69 0.0006
978 INJECTION SITE ERYTHEMA 68 0.0005
979 SUICIDE ATTEMPT 33 0.0005
980 NEUTROPENIA 74 0.0005
981 INJECTION SITE PAIN 166 0.0005
982 INJECTION SITE SWELLING 40 0.0005
983 DEVICE USE ERROR 17 0.0005
984 PRODUCT ADHESION ISSUE 17 0.0005
985 COMA 22 0.0005
986 DEVICE DIFFICULT TO USE 29 0.0004
987 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
988 ACNE 28 0.0004
989 INJECTION SITE HAEMORRHAGE 28 0.0004
990 TOXICITY TO VARIOUS AGENTS 46 0.0003